RE: Recurring Revenus Rampup
agreed...
I would actually like to see the company give the market a clearer sense of what a "succesful drug" means in terms of Gel sales and technology transfer relative to the revenue we're seeing that's generally "research or clinical" quantities. Its obviously a reasonable likelihood that one or more of these Pharma co's initiatives will be successful. It gets really compelling when you start to think of a larger group of regular clients buying for both clinical and production needs, especially when you throw frac and purification plants into the mix
like you said... potentially exponential growth